Sheaff Brock Investment Advisors, LLC Sarepta Therapeutics, Inc. Transaction History

Sheaff Brock Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$72.25 - $168.95 $101,150 - $236,529	-1,400 Closed	0 $0
Q4 2020 Feb 01, 2021	BUY	$125.56 - $178.74 $175,784 - $250,236	1,400 New	1,400 $239,000
Q3 2020 Oct 30, 2020	SELL	$127.12 - $172.34 $381,360 - $517,020	-3,000 Closed	0 $0
Q3 2019 Oct 28, 2019	BUY	$72.81 - $156.91 $98,293 - $211,828	1,350 Added 81.82%	3,000 $226,000
Q2 2019 Jul 31, 2019	BUY	$112.21 - $151.95 $185,146 - $250,717	1,650 New	1,650 $251,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.